Extracellular Vesicles and Their Mimetics : A Comparative Study of Their Pharmacological Activities and Immunogenicity Profiles
Extracellular vesicles (EVs), which are miniaturised carriers loaded with functional proteins, lipids, and nucleic acid material, are naturally secreted by cells and show intrinsic pharmacological effects in several conditions. As such, they have the potential to be used for the treatment of various human diseases. However, the low isolation yield and laborious purification process are obstacles to their translation for clinical use. To overcome this problem, our lab developed cell-derived nanovesicles (CDNs), which are EV mimetics produced by shearing cells through membrane-fitted spin cups. To evaluate the similarities between EVs and CDNs, we compare the physical properties and biochemical composition of monocytic U937 EVs and U937 CDNs. Besides having similar hydrodynamic diameters, the produced CDNs had proteomic, lipidomic, and miRNA profiles with key communalities compared to those of natural EVs. Further characterisation was conducted to examine if CDNs could exhibit similar pharmacological activities and immunogenicity when administered in vivo. Consistently, CDNs and EVs modulated inflammation and displayed antioxidant activities. EVs and CDNs both did not exert immunogenicity when administered in vivo. Overall, CDNs could serve as a scalable and efficient alternative to EVs for further translation into clinical use.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:15 |
|---|---|
| Enthalten in: |
Pharmaceutics - 15(2023), 4 vom: 20. Apr. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Chng, Wei Heng [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Cell-derived nanovesicles |
|---|
| Anmerkungen: |
Date Revised 01.05.2023 published: Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.3390/pharmaceutics15041290 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM356153495 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM356153495 | ||
| 003 | DE-627 | ||
| 005 | 20231226065846.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3390/pharmaceutics15041290 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1187.xml |
| 035 | |a (DE-627)NLM356153495 | ||
| 035 | |a (NLM)37111775 | ||
| 035 | |a (PII)1290 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Chng, Wei Heng |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Extracellular Vesicles and Their Mimetics |b A Comparative Study of Their Pharmacological Activities and Immunogenicity Profiles |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 01.05.2023 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a Extracellular vesicles (EVs), which are miniaturised carriers loaded with functional proteins, lipids, and nucleic acid material, are naturally secreted by cells and show intrinsic pharmacological effects in several conditions. As such, they have the potential to be used for the treatment of various human diseases. However, the low isolation yield and laborious purification process are obstacles to their translation for clinical use. To overcome this problem, our lab developed cell-derived nanovesicles (CDNs), which are EV mimetics produced by shearing cells through membrane-fitted spin cups. To evaluate the similarities between EVs and CDNs, we compare the physical properties and biochemical composition of monocytic U937 EVs and U937 CDNs. Besides having similar hydrodynamic diameters, the produced CDNs had proteomic, lipidomic, and miRNA profiles with key communalities compared to those of natural EVs. Further characterisation was conducted to examine if CDNs could exhibit similar pharmacological activities and immunogenicity when administered in vivo. Consistently, CDNs and EVs modulated inflammation and displayed antioxidant activities. EVs and CDNs both did not exert immunogenicity when administered in vivo. Overall, CDNs could serve as a scalable and efficient alternative to EVs for further translation into clinical use | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a cell-derived nanovesicles | |
| 650 | 4 | |a exosome mimetics | |
| 650 | 4 | |a extracellular vesicles | |
| 650 | 4 | |a immunogenicity | |
| 650 | 4 | |a small extracellular vesicles | |
| 700 | 1 | |a Muthuramalingam, Ram Pravin Kumar |e verfasserin |4 aut | |
| 700 | 1 | |a Lou, Charles Kang Liang |e verfasserin |4 aut | |
| 700 | 1 | |a New, Silas |e verfasserin |4 aut | |
| 700 | 1 | |a Neupane, Yub Raj |e verfasserin |4 aut | |
| 700 | 1 | |a Lee, Choon Keong |e verfasserin |4 aut | |
| 700 | 1 | |a Altay Benetti, Ayca |e verfasserin |4 aut | |
| 700 | 1 | |a Huang, Chenyuan |e verfasserin |4 aut | |
| 700 | 1 | |a Thoniyot, Praveen |e verfasserin |4 aut | |
| 700 | 1 | |a Toh, Wei Seong |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Jiong-Wei |e verfasserin |4 aut | |
| 700 | 1 | |a Pastorin, Giorgia |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Pharmaceutics |d 2010 |g 15(2023), 4 vom: 20. Apr. |w (DE-627)NLM204303303 |x 1999-4923 |7 nnns |
| 773 | 1 | 8 | |g volume:15 |g year:2023 |g number:4 |g day:20 |g month:04 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3390/pharmaceutics15041290 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 15 |j 2023 |e 4 |b 20 |c 04 | ||